Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae (CRE) Carriers Impacts Transmission.

Bartsch SM, Wong KF, Stokes-Cawley OJ, McKinnell JA, Cao C, Gussin GM, Mueller LE, Kim DS, Miller LG, Huang SS, Lee BY.

J Infect Dis. 2019 May 31. pii: jiz288. doi: 10.1093/infdis/jiz288. [Epub ahead of print]

PMID:
31150539
2.

Postdischarge Infection Risk among MRSA Carriers. Reply.

Huang SS, McKinnell JA, Miller LG.

N Engl J Med. 2019 May 30;380(22):2182. doi: 10.1056/NEJMc1903763. No abstract available.

PMID:
31141648
3.

A Bayesian model of acquisition and clearance of bacterial colonization incorporating within-host variation.

Järvenpää M, Sater MRA, Lagoudas GK, Blainey PC, Miller LG, McKinnell JA, Huang SS, Grad YH, Marttinen P.

PLoS Comput Biol. 2019 Apr 22;15(4):e1006534. doi: 10.1371/journal.pcbi.1006534. eCollection 2019 Apr.

4.

Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated.

Lee BY, Bartsch SM, Wong KF, Kim DS, Cao C, Mueller LE, Gussin GM, McKinnell JA, Miller LG, Huang SS.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):731-734. doi: 10.1017/ice.2019.61. Epub 2019 Mar 28. No abstract available.

5.

Once-Daily Plazomicin for Complicated Urinary Tract Infections.

Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group.

N Engl J Med. 2019 Feb 21;380(8):729-740. doi: 10.1056/NEJMoa1801467.

PMID:
30786187
6.

Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.

Huang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, Gillen DL, Kim D, Rashid S, Macias-Gil R, Bolaris MA, Tjoa T, Cao C, Hong SS, Lequieu J, Cui E, Chang J, He J, Evans K, Peterson E, Simpson G, Robinson P, Choi C, Bailey CC Jr, Leo JD, Amin A, Goldmann D, Jernigan JA, Platt R, Septimus E, Weinstein RA, Hayden MK, Miller LG; Project CLEAR Trial.

N Engl J Med. 2019 Feb 14;380(7):638-650. doi: 10.1056/NEJMoa1716771.

PMID:
30763195
7.

The SHIELD Orange County Project -Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California.

McKinnell JA, Singh RD, Miller LG, Kleinman K, Gussin G, He J, Saavedra R, Dutciuc TD, Estevez M, Chang J, Heim L, Yamaguchi S, Custodio H, Gohil SK, Park S, Tam S, Robinson PA, Tjoa T, Nguyen J, Evans KD, Bittencourt CE, Lee BY, Mueller LE, Bartsch SM, Jernigan JA, Slayton RB, Stone ND, Zahn M, Mor V, McConeghy K, Baier RR, Janssen L, O'Donnell K, Weinstein RA, Hayden MK, Coady MH, Bhattarai M, Peterson EM, Huang SS; CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program.

Clin Infect Dis. 2019 Feb 11. doi: 10.1093/cid/ciz119. [Epub ahead of print]

PMID:
30753383
8.

Bacterial burden is associated with increased transmission to health care workers from patients colonized with vancomycin-resistant Enterococcus.

Jackson SS, Harris AD, Magder LS, Stafford KA, Johnson JK, Miller LG, Calfee DP, Thom KA; CDC Prevention Epicenters Program.

Am J Infect Control. 2019 Jan;47(1):13-17. doi: 10.1016/j.ajic.2018.07.011. Epub 2018 Sep 26.

PMID:
30268592
9.

Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites.

Miller LG.

Clin Infect Dis. 2019 Mar 19;68(7):1223-1224. doi: 10.1093/cid/ciy720. No abstract available.

PMID:
30137243
10.

Metabolic Capability and Phylogenetic Diversity of Mono Lake during a Bloom of the Eukaryotic Phototroph Picocystis sp. Strain ML.

Stamps BW, Nunn HS, Petryshyn VA, Oremland RS, Miller LG, Rosen MR, Bauer KW, Thompson KJ, Tookmanian EM, Waldeck AR, Loyd SJ, Johnson HA, Stevenson BS, Berelson WM, Corsetti FA, Spear JR.

Appl Environ Microbiol. 2018 Oct 17;84(21). pii: e01171-18. doi: 10.1128/AEM.01171-18. Print 2018 Nov 1.

11.

Lack of uniformity among United States recommendations for diagnosis and management of acute, uncomplicated cystitis.

Markowitz MA, Wood LN, Raz S, Miller LG, Haake DA, Kim JH.

Int Urogynecol J. 2019 Jul;30(7):1187-1194. doi: 10.1007/s00192-018-3750-z. Epub 2018 Aug 11.

PMID:
30099566
12.

Patient contact is the main risk factor for vancomycin-resistant Enterococcus contamination of healthcare workers' gloves and gowns in the intensive care unit.

Jackson SS, Thom KA, Magder LS, Stafford KA, Johnson JK, Miller LG, Calfee DP, Harris AD; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1063-1067. doi: 10.1017/ice.2018.160. Epub 2018 Jul 27.

PMID:
30051793
13.

Acetylenotrophy: a hidden but ubiquitous microbial metabolism?

Akob DM, Sutton JM, Fierst JL, Haase KB, Baesman S, Luther GW 3rd, Miller LG, Oremland RS.

FEMS Microbiol Ecol. 2018 Aug 1;94(8). doi: 10.1093/femsec/fiy103. Review.

PMID:
29933435
14.

Pregnancy Screening and Monitoring of Albendazole Therapy for Neurocysticercosis.

Persichino JG, Miller LG.

Clin Infect Dis. 2018 Nov 13;67(11):1797-1798. doi: 10.1093/cid/ciy436. No abstract available.

PMID:
29790912
15.

Bayesian evidence and epidemiological implications of environmental contamination from acute respiratory infection in long-term care facilities.

Diaz-Decaro JD, Launer B, Mckinnell JA, Singh R, Dutciuc TD, Green NM, Bolaris M, Huang SS, Miller LG.

Epidemiol Infect. 2018 May;146(7):832-838. doi: 10.1017/S0950268818000729. Epub 2018 Apr 10.

PMID:
29633685
16.

Early Serum Gut Hormone Concentrations Associated With Time to Full Enteral Feedings in Preterm Infants.

Shanahan KH, Yu X, Miller LG, Freedman SD, Martin CR.

J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):97-102. doi: 10.1097/MPG.0000000000001987.

PMID:
29620597
17.

The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae Toolkit.

Bartsch SM, Huang SS, McKinnell JA, Wong KF, Mueller LE, Miller LG, Lee BY.

Infect Control Hosp Epidemiol. 2018 May;39(5):516-524. doi: 10.1017/ice.2018.49. Epub 2018 Mar 19.

18.

Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

Dillen CA, Pinsker BL, Marusina AI, Merleev AA, Farber ON, Liu H, Archer NK, Lee DB, Wang Y, Ortines RV, Lee SK, Marchitto MC, Cai SS, Ashbaugh AG, May LS, Holland SM, Freeman AF, Miller LG, Yeaman MR, Simon SI, Milner JD, Maverakis E, Miller LS.

J Clin Invest. 2018 Mar 1;128(3):1026-1042. doi: 10.1172/JCI96481. Epub 2018 Feb 5.

19.

A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.

Connolly LE, Riddle V, Cebrik D, Armstrong ES, Miller LG.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01989-17. doi: 10.1128/AAC.01989-17. Print 2018 Apr.

20.

Cephalexin plus trimethoprim-sulfamethoxazole was not superior to cephalexin alone for the treatment of outpatient non-purulent cellulitis.

Miller LG.

Evid Based Med. 2017 Dec;22(6):213. doi: 10.1136/ebmed-2017-110796. Epub 2017 Nov 10. Review. No abstract available.

PMID:
29127212
21.

A Case of Early Prosthetic Valve Endocarditis Caused by Staphylococcus warneri in a Patient Presenting With Congestive Heart Failure.

Kuvhenguhwa MS, Belgrave KO, Shah SU, Bayer AS, Miller LG.

Cardiol Res. 2017 Oct;8(5):236-240. doi: 10.14740/cr588w. Epub 2017 Oct 27.

22.

Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.

Yarbrough ML, Warren DK, Allen K, Burkholder D, Daum R, Donskey C, Knaack D, LaMarca A, May L, Miller LG, Parenti DM, Peterson L, Tan TY, Widen R, Hernandez DR, Wolk DM, Burnham CA.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01381-17. doi: 10.1128/JCM.01381-17. Print 2018 Jan.

23.

Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

Humphries RM, Hindler JA, Epson E, Horwich-Scholefield S, Miller LG, Mendez J, Martinez JB, Sinkowitz J, Sinkowtiz D, Hershey C, Marquez P, Bhaurla S, Moran M, Pandes L, Terashita D, McKinnell JA.

Clin Infect Dis. 2018 Mar 19;66(7):1061-1067. doi: 10.1093/cid/cix942.

PMID:
29099915
24.

A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.

Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF; DMID 07-0051 Team.

N Engl J Med. 2017 Jun 29;376(26):2545-2555. doi: 10.1056/NEJMoa1607033.

25.

Discontinuation of contact precautions with the introduction of universal daily chlorhexidine bathing.

McKinnell JA, Eells SJ, Clark E, Rand DD, Kiet GT, Macias-Gil R, Mendez JM, Huang SS, Milefchik EN, Miller LG.

Epidemiol Infect. 2017 Sep;145(12):2575-2581. doi: 10.1017/S0950268817001121. Epub 2017 Jun 9.

26.

Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.

Miller LG Jr, Young JA, Ray SK, Wang G, Purohit S, Banik NL, Dasgupta S.

Neurochem Res. 2017 Oct;42(10):2755-2768. doi: 10.1007/s11064-017-2280-2. Epub 2017 May 5.

PMID:
28474276
27.

Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Doernberg SB, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL; Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828. Review.

28.

Incidence and factors associated with emergency department visits for recurrent skin and soft tissue infections in patients in California, 2005-2011.

May L, Klein EY, Martinez EM, Mojica N, Miller LG.

Epidemiol Infect. 2017 Mar;145(4):746-754. doi: 10.1017/S0950268816002855. Epub 2016 Dec 5.

PMID:
27917738
29.

Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.

Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller LG.

mSphere. 2016 Nov 23;1(6). pii: e00314-16. eCollection 2016 Nov-Dec.

30.

Therapy for Cellulitis.

Miller LG.

JAMA. 2016 Nov 15;316(19):2046. doi: 10.1001/jama.2016.15610. No abstract available.

PMID:
27838714
31.

Status of the Prevention of Multidrug-Resistant Organisms in International Settings: A Survey of the Society for Healthcare Epidemiology of America Research Network.

Safdar N, Sengupta S, Musuuza JS, Juthani-Mehta M, Drees M, Abbo LM, Milstone AM, Furuno JP, Varman M, Anderson DJ, Morgan DJ, Miller LG, Snyder GM; SHEA Research Committee.

Infect Control Hosp Epidemiol. 2017 Jan;38(1):53-60. doi: 10.1017/ice.2016.242. Epub 2016 Nov 7.

PMID:
27817759
32.

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY.

Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16. doi: 10.1016/j.cmi.2016.09.003. Epub 2016 Sep 15.

33.

Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes.

McKinnell JA, Miller LG, Singh R, Kleinman K, Peterson EM, Evans KD, Dutciuc TD, Heim L, Gombosev A, Estevez M, Launer B, Tjoa T, Tam S, Bolaris MA, Huang SS.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1485-1488. Epub 2016 Sep 27.

PMID:
27671022
34.

Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.

McKINNELL JA, Kunz DF, Moser SA, Vangala S, Tseng CH, Shapiro M, Miller LG.

Epidemiol Infect. 2016 Jun;144(8):1748-55. doi: 10.1017/S0950268815003118.

35.

Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections.

Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2941-8. doi: 10.1128/AAC.02626-15. Print 2016 May.

36.

Beyond the Intensive Care Unit (ICU): Countywide Impact of Universal ICU Staphylococcus aureus Decolonization.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Cui E, Cao C, Kim DS, Miller LG, Huang SS.

Am J Epidemiol. 2016 Mar 1;183(5):480-9. doi: 10.1093/aje/kww008. Epub 2016 Feb 11.

37.

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, Huang SS.

Am J Epidemiol. 2016 Mar 1;183(5):471-9. doi: 10.1093/aje/kwv299. Epub 2016 Feb 8.

38.

Treatment for Positive Urine Cultures in Hospitalized Adults: A Survey of Prevalence and Risk Factors in 3 Medical Centers.

Grein JD, Kahn KL, Eells SJ, Choi SK, Go-Wheeler M, Hossain T, Riva MY, Nguyen MH, Rekha Murthy A, Miller LG.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):319-26. doi: 10.1017/ice.2015.281. Epub 2015 Nov 26.

39.

Stable Carbon Isotope Fractionation during Bacterial Acetylene Fermentation: Potential for Life Detection in Hydrocarbon-Rich Volatiles of Icy Planet(oid)s.

Miller LG, Baesman SM, Oremland RS.

Astrobiology. 2015 Nov;15(11):977-86. doi: 10.1089/ast.2015.1355. Epub 2015 Nov 5.

40.

Microbiological oxidation of antimony(III) with oxygen or nitrate by bacteria isolated from contaminated mine sediments.

Terry LR, Kulp TR, Wiatrowski H, Miller LG, Oremland RS.

Appl Environ Microbiol. 2015 Dec;81(24):8478-88. doi: 10.1128/AEM.01970-15. Epub 2015 Oct 2.

41.

A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

May LS, Rothman RE, Miller LG, Brooks G, Zocchi M, Zatorski C, Dugas AF, Ware CE, Jordan JA.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1423-30. doi: 10.1017/ice.2015.202. Epub 2015 Aug 26.

42.

Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010.

Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, Wallace A, Fang C, Singer J, Suaya JA.

BMC Infect Dis. 2015 Aug 21;15:362. doi: 10.1186/s12879-015-1071-0.

43.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.

Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NT, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA.

MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31.

44.

Antibacterial Treatment for Uncomplicated Skin Infections.

Miller LG, Daum RS, Chambers HF.

N Engl J Med. 2015 Jun 18;372(25):2460. doi: 10.1056/NEJMc1504843. No abstract available.

PMID:
26083210
45.

Reply to O'Riordan et al.

McKinnell JA, Bartsch SM, Lee BY, Huang SS, Miller LG.

Infect Control Hosp Epidemiol. 2015 Jul;36(7):857-8. doi: 10.1017/ice.2015.112. No abstract available.

46.

The association of patient complexities with antibiotic ordering.

Wooten D, Kahn K, Grein JD, Eells SJ, Miller LG.

J Hosp Med. 2015 Jul;10(7):446-52. doi: 10.1002/jhm.2367. Epub 2015 Apr 15.

PMID:
25873035
47.

USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus.

Boyle-Vavra S, Li X, Alam MT, Read TD, Sieth J, Cywes-Bentley C, Dobbins G, David MZ, Kumar N, Eells SJ, Miller LG, Boxrud DJ, Chambers HF, Lynfield R, Lee JC, Daum RS.

MBio. 2015 Apr 7;6(2). pii: e02585-14. doi: 10.1128/mBio.02585-14.

48.

Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.

Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, Pettibone S, Hoagland RJ, Chambers HF; DMID 07-0051 Team.

N Engl J Med. 2015 Mar 19;372(12):1093-103. doi: 10.1056/NEJMoa1403789.

49.

Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing.

Alam MT, Read TD, Petit RA 3rd, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ.

MBio. 2015 Mar 10;6(2):e00054. doi: 10.1128/mBio.00054-15.

50.

Risk factors for central line-associated bloodstream infections in the era of prevention bundles.

Callister D, Limchaiyawat P, Eells SJ, Miller LG.

Infect Control Hosp Epidemiol. 2015 Feb;36(2):214-6. doi: 10.1017/ice.2014.32.

PMID:
25633005

Supplemental Content

Loading ...
Support Center